Limertinib (OuyiXin®) is a third-generation EGFR tyrosine kinase inhibitor (EGFR‑TKI) at 80 mg per tablet, 20 tablets per box, from Jiangsu Osscon Pharmaceutical. Approved by China’s NMPA under H20250004, it…
Limertinib (OuyiXin®) is a third-generation EGFR tyrosine kinase inhibitor (EGFR‑TKI) at 80 mg per tablet, 20 tablets per box, from Jiangsu Osscon Pharmaceutical. Approved by China’s NMPA under H20250004, it…
Oh and I'll be doing a talk on and demo with the IoT weather station me and a peer reversed!
Oh and I'll be doing a talk on and demo with the IoT weather station me and a peer reversed!